Zeta Global Holdings reports Q1 2026 results on May 5 against a backdrop of rising short interest, freshly upgraded analyst coverage, and a stock that has recovered sharply off its lows — a rare combination that sets up a pointed test of the company's growth narrative.
Short sellers have grown more active heading into the print. Short interest has climbed to 12.8% of the free float — about 27.7 million shares — up roughly 5% over the past week. That's a meaningful short position for an application-software name, and it has been building steadily since mid-April. The ORTEX short score sits at 62.2, near the top of its recent range, reflecting elevated short conviction. Borrow costs are still manageable at 0.47% annualised and have not spiked. Availability remains adequate, so there is no acute lending-market squeeze — this is a position being built deliberately, not a forced situation.
Options traders are telling a different story. The put/call ratio has nudged up to 0.35, marginally above its 20-day average of 0.32 and roughly one standard deviation elevated — but in absolute terms it remains low. The 52-week high for the ratio is 0.64, so current options positioning is still skewed firmly toward calls. Combined with a 17% price gain over the past month and a 6% gain just this week, the options picture points to residual optimism rather than serious hedging demand. The two signals diverge: short sellers are building, but options traders remain net constructive.
The analyst community has turned visibly more positive in the days before the print. Keybanc upgraded to Overweight on April 29, initiating a $22 target, while RBC raised its target to $29 just yesterday, reiterating Outperform. Goldman maintains Neutral with a $26 target, and Morgan Stanley holds Equal-Weight at $27 — the mean consensus target is $28.77, roughly 55% above the current $18.60 close, which ranks the stock in the 98th percentile for analyst return potential across the universe. The bull case centres on Zeta's marketing-automation platform, consistent earnings beats, and ARPU expansion from scaled customers. The bear case focuses on integration risk from the Marigold acquisition and the competitive intensity of the enterprise marketing stack. The company's 12-month forward EPS growth estimate ranks in the 89th percentile — a strong growth signal — though the EPS surprise rank (12th percentile) and softer recent EPS momentum suggest the bar is not especially low heading in.
The one confirmed prior earnings reaction in the dataset shows the stock gained 4.4% in the session following the last print, with an earlier event delivering a 6.4% day-one move and a 10.5% five-day gain. The May 5 print is less about confirming growth and more about whether Zeta can demonstrate that Marigold integration costs are not eroding the margin profile that justified the stock's recent recovery — and whether the expanding short base has identified something the upgrading analysts have not.
See the live data behind this article on ORTEX.
Open ZETA on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
